Browse our anti-Protein Kinase D1 (PRKD1) Antibodies

Zebrafish Protein Kinase D1 (PRKD1) interaction partners

1. cloning and expression analysis of a protein kinase C (show PKC Antibodies) gene, PKCmu, and its regulation of the promoter region (PKCmu)

2. PKD1 (show PKD1 Antibodies) contributes to the regulation of physiological angiogenesis and lymphangiogenesis during zebrafish development and is essential for tumor angiogenesis.

Human Protein Kinase D1 (PRKD1) interaction partners

1. these results describe a novel mechanism governing PRKD1 gene expression in pancreatic ductal adenocarcinoma and provide a functional link between oncogenic KRas, NF-kappaB (show NFKB1 Antibodies) and expression of PRKD1.

2. p110alpha (show PIK3CA Antibodies) subunit of PI3K (show PIK3CA Antibodies) and PKD mediate YAP (show YAP1 Antibodies) activation in response to insulin (show INS Antibodies) and neurotensin (show NTS Antibodies) in pancreatic cancer cells. Inhibitors of PI3K (show PIK3CA Antibodies) or PKD disrupt crosstalk between insulin receptor (show INSR Antibodies) and GPCR (show NMUR1 Antibodies) signaling systems by blocking YAP (show YAP1 Antibodies)/TEAD-regulated gene expression in pancreatic cancer cells

3. High PRKD1 expression is associated with drug resistance in breast cancer.

4. Our findings directly associate the AR/NCOA1 (show NCOA1 Antibodies) complex with PRKD1 regulation and cellular migration and support the concept of therapeutic inhibition of NCOA1 (show NCOA1 Antibodies) in prostate cancer.

5. None of the Polymorphous low-grade adenocarcinoma (PLGA) lacking PRKD1 somatic mutations or PRKD gene family rearrangements harboured somatic mutations in the kinase domains of the PRKD2 (show PKD2 Antibodies) or PRKD3 (show PRKD3 Antibodies) genes.

6. A single nucleotide polymorphism located within the fourth intron of PRKD1 (rs57803087) was strongly associated with DPP-4 (show DPP4 Antibodies) inhibitor response in patients with type 2 diabetes

7. Mutation in PRKD1 gene is associated with congenital heart defects.

8. Bradykinin stimulates myofibroblast migration through protein kinase D-mediated activation of COX-2 (show COX2 Antibodies) and Hsp27 (show HSPB1 Antibodies).

9. Lysophosphatidic acid/PKD-1 (show PKD1 Antibodies) signaling leads to nuclear accumulation of histone deacetylase 7 (show HDAC7 Antibodies), where it interacts with forkhead box protein O1 (show FOXO1 Antibodies) to suppress endothelial CD36 (show CD36 Antibodies) transcription and mediates silencing of antiangiogenic switch, resulting in proangiogenic and proarteriogenic reprogramming.

10. This study discovered and characterized a novel, highly conserved N-terminal domain, comprising 92 amino acids, which mediates dimerization of Protein Kinase D (PKD) isoforms, PKD1 (show PKD1 Antibodies), PKD2 (show PKD2 Antibodies), and PKD3 (show PRKD3 Antibodies) monomers.

Mouse (Murine) Protein Kinase D1 (PRKD1) interaction partners

1. The study demonstrates an essential role for PKD1 (show PKD1 Antibodies) in the beta-cell adaptive secretory response to high-fat feeding in mice.

2. These findings imply that PKD1 (show PKD1 Antibodies) plays a critical regulatory role in Group B streptococci (GBS (show GNB5 Antibodies))-induced proinflammatory reactions and sepsis, and inhibition of PKD1 (show PKD1 Antibodies) activation together with antibiotic treatment in GBS (show GNB5 Antibodies)-infected neonates could be an effective way to control GBS (show GNB5 Antibodies) diseases.

3. Lysophosphatidic acid/PKD-1 (show PKD1 Antibodies) signaling leads to nuclear accumulation of histone deacetylase 7 (show HDAC7 Antibodies), where it interacts with forkhead box protein O1 (show FOXO1 Antibodies) to suppress endothelial CD36 (show CD36 Antibodies) transcription and mediates silencing of antiangiogenic switch, resulting in proangiogenic and proarteriogenic reprogramming.

4. Our studies demonstrate that PKD1 (show PKD1 Antibodies)/2 is a key regulator of MVB maturation and exosome secretion, and constitutes a mediator of the DGK alpha (show DGKA Antibodies) effect on MVB secretory traffic.

5. Our results show that AKAP13 (show AKAP13 Antibodies)-PKD1 (show PKD1 Antibodies) signaling is critical for transcriptional regulation of key contractile, cell death, and metabolic pathways during the development of compensatory hypertrophy in vivo.

6. PKD1 (show PKD1 Antibodies) acts downstream of TGFalpha and Kras, to mediate formation of ductal structures through activation of the Notch (show NOTCH1 Antibodies) pathway.

7. Results reveal that whereas protein kinase D1 and protein kinase D2 (show PKD2 Antibodies) are essential for neuronal polarity, there exists a functional redundancy between the two proteins.

8. PKD controls synaptic plasticity and learning by regulating actin stability in dendritic spines.

9. regulatory kinase of eNOS (show NOS3 Antibodies) in endothelial cells whose activity orchestrates mammalian vascular tone

10. Overexpression of constitutively active PKD1 (show PKD1 Antibodies) in rodent heart results in dilated cardiomyopathy.

Cow (Bovine) Protein Kinase D1 (PRKD1) interaction partners

1. AngII activates PKD via a mechanism involving Src family kinases and PKC, to underlie increased aldosterone production.

2. Data indicate that Ser738/742-to-glutamate (show GRIN2A Antibodies) protein kinase D mutant increased AngII-induced CREB (show CREB1 Antibodies) protein and activating transcription factor 2 (show ATF2 Antibodies) phosphorylation, and phospho-CREB (show CREB1 Antibodies) binding to the steroidogenic acute regulatory protein (show STAR Antibodies) promoter.

3. These results indicate that PKD is downstream of PLD (show PLD Antibodies) and suggest that PKD is one of the mechanisms through which PLD (show PLD Antibodies) promotes aldosterone production in response to AngII in adrenal glomerulosa cells.

4. PKD mediates acute AngII-induced aldosterone secretion.

5. Protein kinase D-HDAC5 (show HDAC5 Antibodies) pathway plays an important role in VEGF (show VEGFA Antibodies) regulation of gene transcription and angiogenesis